We evaluated the tumour proportion scores (TPSs) and immune proportion scores (IPSs) for CTLA-4 and PD-L1 immunoexpression in thyroid tumours and correlated them with clinicopathological parameters. This evidence concerns the gene CTLA4 and thyroid tumor.